Ventricular Tachycardia With Participation of the Left Bundle-Purkinje System in Patients With Structural Heart Disease: Identification of Slow Conduction During Sinus Rhythm


  • Manuscript received 31 January 2007; Revised manuscript received 11 April 2007; Accepted for publication 24 April 2007.

Address for correspondence: Dr. Christopher Reithmann, Medizinische Klinik I, Klinikum Grosshadern, Universität München, Marchioninistr. 15, D-81377 München, Germany. Fax: +49/8970958830; E-mail:


Introduction: Idiopathic left ventricular tachycardia (VT) originating from the left posterior fascicle can be eliminated by ablation at sites with abnormal diastolic potentials (DPs) during sinus rhythm. We investigated whether such DPs can also be recorded in patients with structural heart disease and VT involving the left bundle-Purkinje system.

Methods and Results: Eight patients (mean age 67 ± 11 years) with nonischemic cardiomyopathy (n = 5) or prior myocardial infarction (n = 3) presented with VT involving the left bundle-Purkinje system (cycle length 376 ± 45 ms). Three types of VT were observed: macroreentrant VT with participation of both left bundle fascicles in three patients, fascicular VT involving the left posterior fascicle in two patients, and scar-related VT with Purkinje fibers as part of the reentrant circuit in three patients. In all patients, abnormal isolated DPs of low amplitude with a QRS—earliest DP interval of 374 ± 86 ms were found during sinus rhythm in the mid- or inferior left ventricular septum in areas with Purkinje potentials. The abnormal DPs during sinus rhythm coincided or were in proximity to DPs during the VT in six patients. VT ablation targeting the sites with the earliest abnormal DPs during sinus eliminated the VT in 7 of 8 patients with freedom from VT recurrence in six patients during the follow-up of 11 ± 5 months.

Conclusions: Isolated DPs during sinus rhythm were found in proximity to the posterior Purkinje network in patients with VT involving the left bundle-Purkinje system associated with heart disease and can be used to guide successful catheter ablation.